United States Human Microbiome Market Report by Product (Probiotics, Prebiotics, Diagnostic Tests, Drugs, Medical Food, and Others), Application (Therapeutics, Diagnostics), Disease Type (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Others), and Region 2024-2032

United States Human Microbiome Market Report by Product (Probiotics, Prebiotics, Diagnostic Tests, Drugs, Medical Food, and Others), Application (Therapeutics, Diagnostics), Disease Type (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A20442

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   United States Human Microbiome Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   United States Human Microbiome Market Landscape
    5.1    Historical and Current Market Trends (2018-2023)
    5.2    Market Forecast (2024-2032)
6   United States Human Microbiome Market - Breakup by Product
    6.1    Probiotics
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2018-2023)
        6.1.3 Market Forecast (2024-2032)
    6.2    Prebiotics
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2018-2023)
        6.2.3 Market Forecast (2024-2032)
    6.3    Diagnostic Tests
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (2018-2023)
        6.3.3 Market Forecast (2024-2032)
    6.4    Drugs
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (2018-2023)
        6.4.3 Market Forecast (2024-2032)
    6.5    Medical Food
        6.5.1 Overview
        6.5.2 Historical and Current Market Trends (2018-2023)
        6.5.3 Market Forecast (2024-2032)
    6.6    Others
        6.6.1 Historical and Current Market Trends (2018-2023)
        6.6.2 Market Forecast (2024-2032)
7   United States Human Microbiome Market - Breakup by Application
    7.1    Therapeutics
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2018-2023)
        7.1.3 Market Forecast (2024-2032)
    7.2    Diagnostics
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2018-2023)
        7.2.3 Market Forecast (2024-2032)
8   United States Human Microbiome Market - Breakup by Disease Type
    8.1    Obesity
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2018-2023)
        8.1.3 Market Forecast (2024-2032)
    8.2    Diabetes
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2018-2023)
        8.2.3 Market Forecast (2024-2032)
    8.3    Autoimmune Disorders
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2018-2023)
        8.3.3 Market Forecast (2024-2032)
    8.4    Cancer
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2018-2023)
        8.4.3 Market Forecast (2024-2032)
    8.5    Gastrointestinal Disorders
        8.5.1 Overview
        8.5.2 Historical and Current Market Trends (2018-2023)
        8.5.3 Market Forecast (2024-2032)
    8.6    Central Nervous System Disorders
        8.6.1 Overview
        8.6.2 Historical and Current Market Trends (2018-2023)
        8.6.3 Market Forecast (2024-2032)
    8.7    Others
        8.7.1 Historical and Current Market Trends (2018-2023)
        8.7.2 Market Forecast (2024-2032)
9   United States Human Microbiome Market – Breakup by Region
    9.1    Northeast
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2018-2023)
        9.1.3 Market Breakup by Product
        9.1.4 Market Breakup by Application
        9.1.5 Market Breakup by Disease Type
        9.1.6 Key Players
        9.1.7 Market Forecast (2024-2032)
    9.2    Midwest
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2018-2023)
        9.2.3 Market Breakup by Product
        9.2.4 Market Breakup by Application
        9.2.5 Market Breakup by Disease Type
        9.2.6 Key Players
        9.2.7 Market Forecast (2024-2032)
    9.3    South
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (2018-2023)
        9.3.3 Market Breakup by Product
        9.3.4 Market Breakup by Application
        9.3.5 Market Breakup by Disease Type
        9.3.6 Key Players
        9.3.7 Market Forecast (2024-2032)
    9.4    West
        9.4.1 Overview
        9.4.2 Historical and Current Market Trends (2018-2023)
        9.4.3 Market Breakup by Product
        9.4.4 Market Breakup by Application
        9.4.5 Market Breakup by Disease Type
        9.4.6 Key Players
        9.4.7 Market Forecast (2024-2032)
10  United States Human Microbiome Market – Competitive Landscape
    10.1    Overview
    10.2    Market Structure
    10.3    Market Player Positioning
    10.4    Top Winning Strategies
    10.5    Competitive Dashboard
    10.6    Company Evaluation Quadrant
11  Profiles of Key Players
    11.1    Company A 
        11.1.1 Business Overview
        11.1.2 Product Portfolio
        11.1.3 Business Strategies
        11.1.4 SWOT Analysis
        11.1.5 Major News and Events
    11.2    Company B
        11.2.1 Business Overview
        11.2.2 Product Portfolio
        11.2.3 Business Strategies
        11.2.4 SWOT Analysis
        11.2.5 Major News and Events
    11.3   Company C
        11.3.1 Business Overview
        11.3.2 Product Portfolio
        11.3.3 Business Strategies
        11.3.4 SWOT Analysis
        11.3.5 Major News and Events
    11.4    Company D 
        11.4.1 Business Overview
        11.4.2 Product Portfolio
        11.4.3 Business Strategies
        11.4.4 SWOT Analysis
        11.4.5 Major News and Events
    11.5    Company E
        11.5.1 Business Overview
        11.5.2 Product Portfolio
        11.5.3 Business Strategies
        11.5.4 SWOT Analysis
        11.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

12  United States Human Microbiome Market - Industry Analysis
    12.1    Drivers, Restraints, and Opportunities
        12.1.1 Overview
        12.1.2 Drivers
        12.1.3 Restraints
        12.1.4 Opportunities
    12.2   Porters Five Forces Analysis
        12.2.1 Overview
        12.2.2 Bargaining Power of Buyers
        12.2.3 Bargaining Power of Suppliers
        12.2.4 Degree of Competition
        12.2.5 Threat of New Entrants
        12.2.6 Threat of Substitutes
    12.3    Value Chain Analysis
13  Appendix

United States Human Microbiome Market Report by Product (Probiotics, Prebiotics, Diagnostic Tests, Drugs, Medical Food, and Others), Application (Therapeutics, Diagnostics), Disease Type (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Others), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials